Malignancy and renal disease.
A variety of renal diseases and electrolyte disorders may be associated with various malignancies or with treatment of malignancy with chemotherapeutic drugs or radiation. This article reviews renal disease in cancer patients, which constitutes a major source of morbidity and mortality.
Kapoor
M
M
Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Chan
G Z
GZ
D058186:Acute Kidney Injury / Q000209:etiology; D000970:Antineoplastic Agents / Q000009:adverse effects; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects; D006530:Hepatorenal Syndrome / Q000150:complications; D006801:Humans; D007674:Kidney Diseases / Q000150:complications*; D008727:Methotrexate / Q000009:adverse effects; D009101:Multiple Myeloma / Q000150:complications; D009369:Neoplasms / Q000150:complications*; D017582:Renal Replacement Therapy
D000970:Antineoplastic Agents; D016572:Cyclosporine; D002945:Cisplatin; D008727:Methotrexate